StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$1.94−0.10 (-4.90%)

Close on Nov 18, 2026Market cap $153.50MP/E 16.2Yield –

Niagen Bioscience operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Niagen Bioscience's operating income for the twelve months ending Sep 30, 2026 was $4.78M, down 75.3% year over year. For fiscal 2025 it was $16.28M, up 110.7% from the year before. The highest annual figure on record is $16.28M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.28M+110.7%
FY2024Dec 31, 2024$7.73M–
FY2023Dec 31, 2023-$5.60M–
FY2022Dec 31, 2022-$18.63M–
FY2021Dec 31, 2021-$27.07M–
FY2020Dec 31, 2020-$19.85M–
FY2019Dec 31, 2019-$31.30M–
FY2018Dec 31, 2018-$33.17M–
FY2017Dec 30, 2017-$16.38M–
FY2016Dec 31, 2016-$2.91M–
FY2015Jan 2, 2016-$2.07M–
FY2014Jan 3, 2015-$5.23M–
FY2013Dec 28, 2013-$4.39M–
FY2012Dec 29, 2012-$11.64M–
FY2011Dec 31, 2011-$7.86M–
FY2010Jan 1, 2011-$2.02M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.59M-137.5%
Q2 FY2026Jun 30, 2026$700.00K-78.0%
Q1 FY2026Mar 31, 2026$1.58M-67.0%
Q4 FY2025Dec 31, 2025$4.09M-42.5%
Q3 FY2025Sep 30, 2025$4.24M+164.4%
Q2 FY2025Jun 30, 2025$3.19M–
Q1 FY2025Mar 31, 2025$4.77M–
Q4 FY2024Dec 31, 2024$7.11M–
Q3 FY2024Sep 30, 2024$1.60M–
Q2 FY2024Jun 30, 2024-$256.00K–
Q1 FY2024Mar 31, 2024-$731.00K–
Q4 FY2023Dec 31, 2023-$168.00K–
Q3 FY2023Sep 30, 2023-$1.15M–
Q2 FY2023Jun 30, 2023-$2.32M–
Q1 FY2023Mar 31, 2023-$1.97M–
Q4 FY2022Dec 31, 2022-$1.44M–
Q3 FY2022Sep 30, 2022-$3.07M–
Q2 FY2022Jun 30, 2022-$6.39M–
Q1 FY2022Mar 31, 2022-$7.73M–
Q4 FY2021Dec 31, 2021-$5.32M–
Q3 FY2021Sep 30, 2021-$8.84M–
Q2 FY2021Jun 30, 2021-$5.55M–
Q1 FY2021Mar 31, 2021-$7.36M–
Q4 FY2020Dec 31, 2020-$6.08M–
Q3 FY2020Sep 30, 2020-$4.20M–
Q2 FY2020Jun 30, 2020-$3.69M–
Q1 FY2020Mar 31, 2020-$5.89M–
Q4 FY2019Dec 31, 2019-$8.86M–
Q3 FY2019Sep 30, 2019-$6.89M–
Q2 FY2019Jun 30, 2019-$7.18M–
Q1 FY2019Mar 31, 2019-$8.37M–
Q4 FY2018Dec 31, 2018-$8.24M–
Q3 FY2018Sep 30, 2018-$8.60M–
Q2 FY2018Jun 30, 2018-$7.94M–
Q1 FY2018Mar 31, 2018-$8.40M–
Q4 FY2017Dec 30, 2017-$8.78M–
Q3 FY2017Sep 30, 2017-$3.18M–
Q4 FY2016Dec 31, 2016-$2.17M–
Q3 FY2016Oct 1, 2016-$924.16K–

More Niagen Bioscience figures

See a number that looks wrong?